A Novel and Simple Method for Laboratory Diagnosis of Relapsing Fever Borreliosis by Larsson, Christer & Bergström, Sven
10 The  Open  Microbiology Journal, 2008, 2, 10-12   
 
  1874-2858/08  2008 Bentham Science Publishers Ltd. 
A Novel and Simple Method for Laboratory Diagnosis of Relapsing Fever 
Borreliosis 
Christer Larsson and Sven Bergström* 
Umeå University, Department of Molecular Biology, Laboratory for Molecular Infection Medicine Sweden (MIMS)  
SE-901 87 Umeå, Sweden  
Abstract: Relapsing fever caused by Borrelia bacteria is often obscured by malaria and incorrectly treated. Here a novel 
method for diagnosis is presented. The method is cheap, simple and requires minimal laboratory material. Despite its sim-
plicity, the method shows surprisingly high sensitivity, detecting concentrations less than 10 bacteria/ml blood.  
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INTRODUCTION 
  Relapsing fever (RF) is a disease caused by several spe-
cies of bacteria belonging to the genus Borrelia. The illness 
occurs worldwide in tropical and sub-tropical areas, but is 
most common in Africa [1, 2]. In some areas, the incidence 
is the highest for any bacterial disease on the continent [3]. 
All species pathogenic to man are transmitted by ticks of the 
genus Ornithodoros with the single exception of B. recur-
rentis, which is transmitted by lice [4, 5]. 
  The main manifestation is, as the name indicates, a recur-
ring fever with massive amounts of bacteria in the blood 
during fever peaks [1, 2, 6]. The relapsing pattern is due to 
the reciprocal action between host antibody response and 
bacterial antigenic variation of surface proteins [7, 8]. How-
ever, fever is a common symptom of many diseases and RF 
is often atypical or causes mild or sub-clinical disease. 
Therefore it is neglected and overlooked in many areas, often 
mistaken as malaria and hence incorrectly treated. In Togo, 
West Africa RF was previously unknown although it was 
recently found to be the causative agent in about 10% of the 
fever patients [9]. The mortality ranges from 2-40% and is 
highest in children. RF also cause pregnancy complications 
such as stillbirth [2]. 
  During fever peaks, diagnosis is simple since there is 
massive bacteraemia easily detected with e.g. the Giemsa 
staining used in malaria diagnosis but between the peaks and 
in milder disease the bacteria are few and very hard to find in 
a stained blood smear by microscopy. Protocols used for 
malaria diagnostics in which water is used to lyse erythro-
cytes usually also lyse spirochetes and are therefore useless 
for RF diagnostics. Phase contrast or dark field microscopy 
directly on10-fold diluted blood is useful when spiro-
chetemia is high. Due to the spirochetes’ thin and transparent 
morphology, ordinary light microscopy is very difficult and 
therefore of limited use. 
  The use of acridine orange–coated quantitative buffy coat 
tubes, centrifugation, and fluorescence microscopy is effec-
tive [10, 11]. However, this technique requires expensive 
equipment seldom available in RF endemic areas.  
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  PCR is an excellent method for RF diagnostics. Briefly, 
DNA is extracted from about 100 l blood, analysed by PCR 
using Borrelia-specific primers and separation on an agarose 
gel, or if using real-time PCR, the results can be directly 
monitored on the computer screen in real time [12, 13]. The 
method is fairly quick and sensitive if the instrument and all 
reagents, including specific primers, are accessible. The ma-
jor drawback with PCR is the cost of necessary equipment 
and reagents. It is also labour intensive and sensitive to con-
tamination, which can result in false positive results. Smaller 
hospitals often have limited possibility of using PCR in their 
diagnostics.  
  ELISA is a valuable scientific tool to screen sera for an-
tibodies against pathogens. Most useful is recombinant 
GlpQ, a protein found in all RF Borrelia but not in other 
related bacteria such as B. burgdorferi or  Treponema. An 
ELISA detecting antibodies recognizing GlpQ identifies pa-
tients who have encountered RF and mounted an immune 
response against the pathogen [9, 14, 15]. RF is an acute 
disease and in most fatal cases, the first attack is most criti-
cal. This lasts for a few days and thereafter it takes another 
couple of days until the fever drops as a result of the host 
antibody response. It is not until this time point that there are 
sufficient antibodies for detection by ELISA. Although supe-
rior in identifying persistent low-grade disease, ELISA is 
expensive and labour intensive. It is more valuable for less 
acute diseases and for epidemiological studies of RF. 
  It is obvious that improved RF diagnostics is urgently 
needed. Therefore, we have developed this centrifugation-
based enrichment method to provide a novel inexpensive and 
simple, but rapid and powerful RF diagnostic method to be 
used in rural health centres and perhaps also at larger hospi-
tals.  
MATERIALS AND METHODS 
Setup of Diagnostics Protocol 
  Blood from healthy volunteers was drawn into hepari-
nised VacuTainer tubes. B. duttonii was grown in BSK II 
culture medium [16] with 1,4% gelatin and 10% rabbit se-
rum (Sigma) at 37°C, washed in phosphate buffered saline 
three times, counted in a Petroff-Hauser chamber using 
phase contrast microscopy. Bacteria were then spiked into 10 
ml blood at known concentrations. The first centrifugation in Relapsing Fever Diagnostics  The Open Microbiology Journal, 2008, Volume 2    11 
which blood cells are separated from the plasma containing 
bacteria was optimized at a speed and duration to obtain a 
supernatant free from erythrocytes and leukocytes without 
lowering the concentration of bacteria. The second centrifu-
gation in which bacteria are pelleted was optimized at a 
speed and duration at which no spirochetes remained in the 
plasma.  
Giemsa Staining and Microscopy 
  The plasma supernatant was aspirated and the almost 
invisible bacterial pellet was resuspended in the few remain-
ing microliters of plasma. The suspension was smeared onto 
a glass slide as a “thick smear” the size of a coin and air-
dried for a few minutes. The smear was then fixed by heating 
a few times over a flame followed by a 30 second dip in 
methanol. Staining was performed by a standard Giemsa 
staining protocol. Stained bacteria were visualized by light 
microscopy at 1000X magnification. Bacteria were either 
stained with Giemsa or directly visualized by phase contrast 
microscopy at 400X.  
RESULTS AND DISCUSSION 
  Although RF is one of the most common bacterial dis-
eases in Africa it is often mistaken, and treated, as malaria, 
especially since they often occur as co-infections [17-19]. If 
effective treatment is given, this is often started only after a 
failed malaria treatment. After finding a 10% incidence of 
RF in fever patients seeking healthcare in Togo, West Af-
rica, although the disease was unknown in the country, we 
realized that the need for improved RF diagnostics is urgent 
[9].  
  Methods such as the quantitative buffy coat technique 
using acridine orange and fluorescent microscopy, PCR with 
RF specific primers and ELISA for e.g. detection of antibod-
ies to RF GlpQ protein are useful in diagnostics [10-15]. 
However, such techniques are often inaccessible, too lengthy 
or too expensive to be used where resources are limited. 
  Therefore we have developed this centrifugation-based 
method to concentrate spirochetes from blood that can be 
used with minimal laboratory equipment (Fig. 1). Methods 
involving ready-made PCR kits, density gradient centrifuga-
tion and Western blot detection of Borrelia proteins were 
initially considered. When we changed perspective and in-
stead focused on the equipment and protocols already avail-
able at small hospital laboratories in RF endemic areas, we 
came to the conclusion that this approach is superior in its 
simplicity, rapidity, low cost and high sensitivity. The choice 
of Giemsa staining as a detection method makes it possible 
to process malaria and RF samples simultaneously since this 
is the stain most widely used in malaria diagnostics. A light 
microscope and Giemsa stain are the very basic equipment 
available at rural health clinic laboratories in malaria en-
demic areas. 
  The availability and quality of centrifuges differ tremen-
dously. The first, slow centrifugation can be performed in 
any centrifuge. This was optimized to obtain a supernatant 
free from erythrocytes with minimal loss of bacteria. Since 
about 1/3 of the blood volume consists of erythrocytes a lot 
of bacteria is lost at this stage anyway. A 5-minute centrifu-
gation at 500 x g was found to be optimal. Naturally, a 
slower/shorter centrifugation will give erythrocyte contami-
nation in the second pellet which will conceal the thin, blue 
bacteria although small amount of erythrocytes is acceptable 
(Fig. 2). At a faster/longer centrifugation the concentration 
of spirochetes in the supernatant gradually decreases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Centrifugation-based enrichment method for spiro-
chetes in blood. Venous blood is drawn into anticoagulant. Blood 
is thereafter centrifuged at 500 x g for 5 minutes, pelleting blood 
cells with most spirochetes remaining in the plasma. After transfer 
to a new test tube, the plasma is centrifuged at 5000 x g for 10 min-
utes to pellet bacteria. The supernatant is decanted, leaving spiro-
chetes in the pellet. The suspended pellet is smeared onto a glass 
slide and stained with Giemsa for microscopic examination at 
1000X magnification. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Borrelia spirochetes concentrated from 10 ml blood and 
Giemsa stained. Low numbers of bacteria were concentrated as 
described in the material and methods section, Giemsa stained and 
visualized by light microscopy at 1000X magnification. Cells 
stained red and blue are contaminating erythrocytes and leukocytes, 
respectively. Some of the bacteria are marked by arrows. 12    The Open Microbiology Journal, 2008, Volume 2  Larsson and Bergström 
  The plasma supernatant was carefully transferred into a 
new centrifuge tube avoiding erythrocyte contamination 
from the pellet. The second centrifugation was designed to 
pellet all bacteria in the remaining plasma. A quite fast cen-
trifugation is necessary to completely pellet all the bacteria. 
We found 5000 x g for 10 minutes to be sufficient but the 
time and speed can be extended without negative side ef-
fects. If the centrifuge is slower than 5000 x g, the time can 
be extended to maximize recovery although slower centrifu-
gation often leaves some bacteria remaining in the super-
natant which may lower the detection limit. Nevertheless, the 
sensitivity will be dramatically higher compared to direct 
microscopy of blood or plasma. 
  To evaluate the sensitivity of the method, 100 bacteria 
were spiked into 10 ml blood. The samples were processed 
as described and about 10 spirochetes were recovered on the 
glass slides by microscopy. This is a concentration of 10 
bacteria/ml and according to our result the laboratory techni-
cian has a fair chance of diagnosing spirochetemia at a bacte-
rial concentration of 1 bacteria/ml. This sensitivity may even 
be superior to many PCR-based protocols where the maxi-
mal volume blood to be used for DNA purification is about 
100 l.  
  If using a regular single-step PCR followed by separation 
with agarose gel electrophoresis and ethidium bromide stain-
ing, it takes approximately 500-1000 cells to get a detectable 
band (personal communication, J. Bunikis). The sensitivity 
can be increased by using nested PCR in which a second 
PCR is performed with two other primers, using the first 
reaction as template [9]. Nested PCR can detect as few as 1-
10 bacteria but is very sensitive to contamination, resulting 
in false positive results. The sensitivity of real-time PCR, in 
which either incorporation of a fluorescent dye or DNA 
probe is measured, is similar to that of nested PCR [20]. By 
combining the methods into nested real time PCR, where an 
ordinary PCR reaction is followed by a real-time PCR with a 
probe and a new set of primers, the sensitivity is as low as 
0.1-1 cell (personal communication, J. Bunikis). The small 
sample volume, typically about 100l, used for DNA prepa-
ration may be more limiting than the sensitivity of the PCR 
methods when spirochetemia is low. By combining the cen-
trifugation protocol with PCR, the sensitivity of RF detection 
can be further increased. 
  Due to its low-tech approach, mainly using equipment 
already available for malaria diagnostics and well-known 
procedures, we believe this novel technique will be very 
valuable for RF diagnostics, especially at rural health centres 
and hospitals. Due to the superior sensitivity it may also be 
considered to be the first-hand choice at larger hospitals, 
when suitable, in combination with PCR. 
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